Shield Therapeutics

Shield is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs.

[Shield Therapeutics @ShieldTx]

https://t.co/RNU6vJqfYG
LSE:STX - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

[Shield Therapeutics @ShieldTx]

We are thrilled to officially welcome our new colleagues from Viatris Inc. to the Shield family. You are joining us at an incredibly exciting moment.
We look forward to seeing what we will achieve together!
https://t.co/RNU6vJqNOe
https://t.co/wiAa3vjp9q

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Total Voting Rights

Check out the full announcement and join in with the conversation at: https://t.co/jYQvosf2gP

#STX

[Shield Therapeutics @ShieldTx]

Shield Therapeutics hosted an investor webinar on assuming full control of ACCRUFeR® in the US.

CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert presented an update, followed by a live Q&A.

🎥 Watch the recording:

https://t.co/Qj2VOAl2zY

[Shield Therapeutics @ShieldTx]

We're excited to announce that Michael Jensen will be joining Shield Therapeutics as Chief Financial Officer today.

Please join us in giving Michael a warm welcome to the team!

[Shield Therapeutics @ShieldTx]

📢 Today at 2:15 pm (BST): Shield Therapeutics present the latest update which announced that Shield will assume full commercial responsibility for ACCRUFeR® in the US.

Still time to register 👇

https://t.co/Qj2VOAl2zY

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Total Voting Rights

Check out the full announcement and join in with the conversation at: https://t.co/6ZIJPQY0aV

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Check out the full announcement and join in with the conversation at: https://t.co/H7opUPxa5y

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Interim results for the six months ended 30 Jun 26

Check out the full announcement and join in with the conversation at: https://t.co/2ZJxQsgeH1

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Total Voting Rights

Check out the full announcement and join in with the conversation at: https://t.co/g5eSM2Rvjg

#STX

[Shield Therapeutics @ShieldTx]

Shield Therapeutics Q2/H1 2026 Trading Update webinar is now live.

Hear from management on the latest commercial progress, financial highlights, and outlook for the year ahead, followed by a live Q&A with investors.

🎥 Watch here:
https://t.co/exY1xDhGxr

[Shield Therapeutics @ShieldTx]

📢 Today at 2:15pm (BST) - our Q2/H1 2026 Trading Update webinar.

CEO Anders Lundstrom, CCO Andy Hurley and Bryon Kallert, Sr Director FP&A, will present our Q2/H1 2026 Trading Update and take questions live from shareholders.

Still time to register 👇

https://t.co/V9RxDNxqcc

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Q2 and H1 2026 Trading Update

Check out the full announcement and join in with the conversation at: https://t.co/zsZpftWgVe

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - ACCRUFeR® Phase 3 pediatric trial published

Check out the full announcement and join in with the conversation at: https://t.co/EeiYHiOwv5

#STX

[Shield Therapeutics @ShieldTx]

Wishing all of our team, partners, and investors across the US a very Happy Independence Day.

Today is a great reminder of the values that inspire progress and the determination to keep building something better.

Enjoy the long weekend, and have a safe and wonderful 4th of July

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Block Listing 6 Monthly Return

Check out the full announcement and join in with the conversation at: https://t.co/aPklTiBQAK

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Results of 2026 Annual General Meeting

Check out the full announcement and join in with the conversation at: https://t.co/9GFiLeceUb

#STX

[Shield Therapeutics @ShieldTx]

We've just released the following announcement: Shield Therapeutics - Total Voting Rights

Check out the full announcement and join in with the conversation at: https://t.co/QGJPRtQ4oQ

#STX

[Shield Therapeutics @ShieldTx]

Today, we mark International Nurses Day, celebrated each year on the birthday of Florence Nightingale to honour the vital contribution nurses make to healthcare worldwide.

#InternationalNursesDay #NursingMatters #Healthcare #NHS #ThankYouNurses

[Shield Therapeutics @ShieldTx]

Shield Therapeutics Q1 2026 Trading Update webinar is now live.

Hear from management on ACCRUFeR® growth and what’s next.

🎥 Watch here:
https://t.co/5DO4sE13uB